1. Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK,
Chadda RK. Magnitude of Substance Use in India. New Delhi:
Ministry of Social Justice and Empowerment, Government of
India; 2019.
2. De Sousa A. The pharmacotherapy of alcohol dependence: a
state-of-the-art review. Mens Sana Monogr. 2010;8(1):69-82.
doi: 10.4103/0973-1229.58820.
3. Ambekar A, Kattimani S. Anti-Craving Medications
in the Treatment of Alcoholism. Manual for long term
pharmacotherapy. National Drug Dependence Treatment
Centre, All India Institute of Medical Sciences, developed
under WHO, Ministry of Health & Family Welfare, Government
of India; 2006.
4. Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont
M, Soyka M. Opioid antagonists for alcohol dependence.
Cochrane Database Syst Rev. 2010(12):CD001867. doi:
10.1002/14651858.CD001867.pub3.
5. Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney
JW. Meta-analysis of naltrexone and acamprosate for treating
alcohol use disorders: when are these medications most
helpful? Addiction. 2013;108(2):275-93. doi: 10.1111/j.1360-
0443.2012.04054.x.
6. Streeton C, Whelan G. Naltrexone, a relapse prevention
maintenance treatment of alcohol dependence: a metaanalysis of randomized controlled trials. Alcohol Alcohol.
2001;36(6):544-52. doi: 10.1093/alcalc/36.6.544.
7. Srisurapanont M, Jarusuraisin N. Naltrexone for the treatment
of alcoholism: a meta-analysis of randomized controlled
trials. Int J Neuropsychopharmacol. 2005;8(2):267-80. doi:
10.1017/s1461145704004997.
8. De Sousa A, De Sousa A. A one-year pragmatic trial
of naltrexone vs disulfiram in the treatment of alcohol
dependence. Alcohol Alcohol. 2004;39(6):528-31. doi:
10.1093/alcalc/agh104.
9. Basu D, Ghosh A, Sarkar S, Patra BN, Subodh BN, Mattoo
SK. Initial treatment dropout in patients with substance use
disorders attending a tertiary care de-addiction centre in
north India. Indian J Med Res. 2017;146(Suppl):S77-84. doi:
10.4103/ijmr.IJMR_1309_15.